Article
[Incidence, clinical markers and prognostic significance of immunologic subtypes of acute lymphoblastic leukemia (ALL) in children: experiences of the ALL-BFM 83 and 86 studies].
Klinische Padiatrie - 1 Jan 2000
Ludwig W D, Teichmann J V, Sperling C, Komischke B, Ritter J, Reiter A, Odenwald E, Sauter S, Riehm H
Abstract excerpt
In the therapy studies ALL-BFM 83 and 86, immunophenotyping of ALL by monoclonal antibodies was performed in a total of 1162 protocol patients (ALL-BFM 83 n = 578; ALL-BFM 86 n = 584). Both studies yielded similar results with respect to the incidence of immunological subtypes: CD10-negative pre-...
Topics
- Antigens, CD
- Antineoplastic Combined Chemotherapy Protocols
- B-Lymphocytes
- Child
- Child, Preschool
- Clinical Trials as Topic
- Female
- Humans
- Infant
- Life Tables
- Male
- Phenotype
- Precursor Cell Lymphoblastic Leukemia-Lymphoma
- Prognosis